Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 25,605 | 46,223 | 5,149 | -105 | 119 |
| Operating Income | -25,605 | -46,223 | -5,149 | 105 | -119 |
| Interest Expense | 5 | 41 | 13 | 3 | 0 |
| Other Income | 121 | -799 | 0 | 0 | 465 |
| Pre-tax Income | -25,489 | -47,063 | -5,162 | 102 | 346 |
| Income Tax | N/A | N/A | N/A | N/A | 73 |
| Net Income Continuous | -25,489 | -46,991 | -5,162 | 102 | 273 |
| Net Income | $-25,489 | $-46,991 | $-5,162 | $102 | $273 |
| EPS Basic Total Ops | -7.10 | -14.63 | -1.50 | 0.03 | 1.00 |
| EPS Basic Continuous Ops | -7.15 | -14.59 | -1.51 | 0.03 | 0.96 |
| EPS Diluted Total Ops | -7.10 | -14.63 | -1.50 | 0.03 | 1.00 |
| EPS Diluted Continuous Ops | -7.15 | -14.58 | -1.51 | 0.03 | 0.96 |
| EBITDA(a) | $-25,605 | $-46,222 | $-5,148 | $105 | $-119 |